Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

FRIDAY, March 7, 2025 (HealthDay News) -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

Novo Nordisk is lowering the price of its weight-loss drug Wegovy to $499 per month for some patients paying out of pocket.

Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.

And on Wednesday the maker of Wegovy, a similar weight-loss drug, announced that it, too, would offer direct-to-consumer ...

Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on Friday, March 1, 2024. (AP Photo/Amanda Andrade-Rhoades, File) Makers of the popular obesity ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their medications elsewhere.

Zepbound (tirzepatide) is an FDA-approved medication for weight management. People need a prescription to buy this medication, and several telemedicine companies offer doctor-led prescription and ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for ... there’s no longer a shortage of weight-loss drugs that had allowed for alternatives ...

ELI LILLY CUTS PRICES FOR ZEPBOUND WEIGHT-LOSS DRUG AGAIN Lilly said its fourth location will expand the company's global manufacturing network for future injectable medicines. "Lilly's optimism ...

(CNN) — Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the ...